Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-164-6 | CAS number: 1760-24-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (Bacterial reverse mutation assay / Ames test): negative with and without metabolic activation in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and Escherichia coli WP2 CM 881 and CM891 (EPA OPPTS 870.5100, similar to OECD TG 471) (DCC (1999)).
Cytogenicity in mammalian cells: testing not required as a reliable in vivo micronucleus is available. Mutagenicity in mammalian cells: negative with and without metabolic activation in CHO cells (EPA Health Effects Test Guidelines HG-Gene Muta-Somatic Cells, similar to OECD TG 476) (Slesinski and Guzzie (1988)).
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-11-10 - 1998-11-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli, other: E coli WP2 trp pKM101 (CM881)
- Species / strain / cell type:
- E. coli, other: E coli WP2 trp uvrA pKM101 (CM891)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9
- Test concentrations with justification for top dose:
- 50, 150, 500, 1500 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: Sponsors choice as completely miscible in water - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- without metabolic activation TA1535 5 µg/plate, TA100 3 µg/plate, CM881 and CM891 2 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA1537 without metabolic activation 30 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA98 without metabolic activation 1 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene 2 µg/plate TA1535, 10 µg/plate CM881 and CM891
- Remarks:
- with metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- TA1537, TA98 and TA100 with metabolic activation 5 µg/plate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
ACTIVATION: S9 mix contained S9 fraction 10%, MgCl, KCl, sodium orthophosphate buffer pH 7.4, glucose-6-phosphate and NADP. 0.5 ml S9 mix and 0.1ml of test solution were added to 2ml agar.
DURATION
- Preincubation period: 30 minutes
- Exposure duration: 3 days
SELECTION AGENT (mutation assays): histidine deficient agar
NUMBER OF REPLICATIONS: triplicate plates, experiment repeated
DETERMINATION OF CYTOTOXICITY
- Method: other: condition of background lawn
ACTIVATION
- Aroclor induced rat liver S9 was present at 10% in the S9 mix, which included NADP and glucolse-6-phosphate as cofactors. 0.5 ml S9 mix was added to 2 ml top agar, 0.1 ml test solution or control and 0.1 ml bacterial culture giving a final concentration of approximately 2%. - Evaluation criteria:
- A result is considered positive if there is a three-fold increase in the number of revertants in TA1535, TA1537 and TA98 over the solvent control and a two-fold increase for other strains. This should occur in both experiments and show some evidence of a dose-relationship. The positive controls must cause at least a doubling of mean revertant colony numbers over the mean of the solvent control.
- Statistics:
- None in report
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli, other: E. coli WP2 pKM101 (CM881)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- N-(3-(trimethoxysilyl)propyl)ethylenediamine has been tested for mutagenicity to bacteria, in a study that was conducted according to the OECD TG 471 and in compliance with GLP. No evidence of test substance related increase in the number of revertants was observed with or without activation in the initial experiment using the plate incorporation method or the repeat pre-incubation assay in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537, E coli WP2 trp uvrA pKM101 (CM891) and E coli WP2 trp pKM101 (CM881). The solvent used was water, and hydrolysis was likely to have occurred under test conditions, so it is assumed that exposure was to the hydrolysis product as well as the parent substance. It is not considered to invalidate the study, as it is considered that hydrolysis may occur in vivo. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988-01-13 to 1988-03-21
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Remarks:
- Insufficient analysable concentrations to meet current guidelines.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- other: EPA Health Effects Test Guidelines HG-Gene Muta-Somatic Cells (1983)
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HGPRT (hypoxanthine-guanine phosphoribosyl transferase)
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Ham's Modified F12 Medium
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: no
- Periodically "cleansed" against high spontaneous background: no - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor-1254 induced rat liver S9
- Test concentrations with justification for top dose:
- without metabolic activation: 2.5, 3.0, 3.25, 3.5 and 4.0 mg/ml, with metabolic activation: 2.0, 2.5, 3.0, 3.5, 4.0 and 4.5 mg/ml
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Remarks:
- cell culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Remarks:
- cell culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-dimethylnitrosamine
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 5 hours (with and without metabolic activation)
- Expression time (cells in growth medium): 9-12 days
SELECTION AGENT (mutation assays): TG selective medium
NUMBER OF REPLICATIONS: Duplicate cultures. Surviving fraction was determined at 18 and 24 hours after removal of chemical using 4 plates per culture and 100 cells per plate; mutant frequency was determined using 5 plates per culture. The test was repeated.
DETERMINATION OF CYTOTOXICITY
- Method: plating efficiency
ACTIVATION: S9 mix contained glucose-6-phosphate and NADP as co-factors, and 5% of S9. 1.0 ml of S9 mix was added to 4 ml of culture medium, giving a final concentration of 1% S9. - Evaluation criteria:
- The criteria for interpretation of the test results as a positive or negative response depend upon both the level of statistical significance from the concurrent control and the evidence of a dose-response effect following treatment. When a definite dose-response relationship is not evident, but one or more marginally significant values are obtained, a careful examination of the data from the concurrent positive and negative controls and comparisons to historical control data may be used to evaluate the probable biological significance of the responses.
- Statistics:
- Box-Cox transformation
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 4.0 mg/ml with metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- N-(3-trimethoxysilyl)propyl)ethylenediamine has been tested in a reliable study according to an appropriate US EPA test guideline that is equivalent to OECD 476 and under GLP. An increase in mutant frequency was observed in one of two duplicate cultures with metabolic activation at one concentration in the initial experiment. No other increase in mutant frequency was observed at any concentration with and without activation (5 hours treatment). The experiment was repeated (with metabolic activation): no increase in mutant frequency was observed. The appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of mutations in CHO cells under the conditions of the test.
Referenceopen allclose all
Average number of revertants per plate (mean of three plates)
Treatment µg/plate |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
CM 881 |
CM 891 |
|||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
Solvent control |
14 |
16 |
9 |
10 |
19 |
23 |
108 |
127 |
46 |
53 |
179 |
180 |
|
50 |
14 |
19 |
7 |
6 |
22 |
27 |
110 |
133 |
56 |
67 |
201 |
190 |
|
150 |
14 |
20 |
7 |
7 |
19 |
24 |
111 |
132 |
63 |
77 |
189 |
203 |
|
500 |
14 |
16 |
7 |
8 |
24 |
24 |
109 |
113 |
46 |
56 |
193 |
203 |
|
1500 |
13 |
16 |
6 |
7 |
25 |
23 |
111 |
123 |
61 |
73 |
199 |
195 |
|
5000 |
10 |
11 |
9 |
9 |
15 |
23 |
87 |
114 |
61 |
63 |
188 |
197 |
|
Positive control |
370 |
179 |
316 |
46 |
115 |
164 |
456 |
718 |
817 |
392 |
1703 |
1799 |
|
Average Revertants per plate with and without metabolic activation – Exp 2 pre-incubation
|
|||||||||||||
Treatment µg/plate |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
CM 881 |
CM 891 |
|||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
||
Solvent control |
18 |
15 |
9 |
9 |
29 |
27 |
134 |
143 |
61 |
69 |
247 |
242 |
|
50 |
20 |
16 |
8 |
11 |
27 |
31 |
115 |
134 |
55 |
73 |
238 |
253 |
|
150 |
18 |
18 |
9 |
10 |
21 |
30 |
110 |
135 |
47 |
66 |
216 |
237 |
|
500 |
13 |
21 |
10 |
9 |
26 |
26 |
106 |
129 |
58 |
62 |
261 |
253 |
|
1500 |
18 |
18 |
7 |
8 |
21 |
28 |
113 |
114 |
54 |
80 |
230 |
235 |
|
5000 |
15 |
18 |
8 |
6 |
25 |
28 |
105 |
97 |
48 |
60 |
215 |
268 |
|
Positive control |
244 |
115 |
120 |
144 |
130 |
270 |
456 |
569 |
792 |
438 |
1569 |
758 |
|
Average Revertants per plate with and without metabolic activation – Exp 1
CHO Mutation Assay: with and without metabolic activation
Results on evaluation of plating efficiency and mutant colonies - Experiment 1
|
Mutant colonies |
Plating efficiency |
||
Test chemical |
(Mean of 5 plates) |
% of Combined Solvent Controls |
||
|
- S9 |
+S9 |
-S9 |
+S9 |
Negative control |
0 |
18 |
106.3 |
105.9 |
Solvent control A |
20 |
2 |
93.7 |
102.3 |
Solvent control B |
0 |
0 |
106.3 |
97.8 |
2.0A |
- |
6 |
- |
120.5 |
2.0B |
- |
13 |
- |
104.4 |
2.5A |
6 |
35 |
103.4 |
107.5 |
2.5B |
1 |
15 |
110.0 |
100.5 |
3.0A |
5 |
4 |
104.6 |
91.0 |
3.0B |
2 |
0 |
124.4 |
109.2 |
3.25A |
5 |
- |
101.1 |
- |
3.25B |
5 |
- |
96.0 |
- |
3.5A |
0 |
0 |
89.4 |
116.0 |
3.5B |
1 |
0 |
103.7 |
107.7 |
4.0A |
0 |
-** |
114.7 |
-** |
4.0B |
5 |
-** |
94.0 |
-** |
Positive control |
143 |
55 |
115.7 |
113.2 |
**= Cytotoxic, cultures did not grow
Results on evaluation of plating efficiency and mutant colonies - Experiment 2
Test chemical
|
Mutant colonies (Mean of 5 plates) |
Plating efficiency |
+S9 |
||
Negative control |
13 |
88.2 |
Solvent control A |
0 |
104.1 |
Solvent control B |
1 |
95.8 |
2.25A |
12 |
118.7 |
2.25B |
0 |
99.7 |
2.5A |
0 |
106.8 |
2.5B |
0 |
111.1 |
2.75A |
0 |
101.9 |
2.75B |
0 |
96.6 |
Positive control |
63 |
92.6 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Micronucleus assay in mouse (ip administration): negative (EPA 560/6-83-001, similar to OECD 474) (BRRC (1988)).
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988-03-15 to 1988-04-08
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Only 1000 cells/animal were scored for micronuclei.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- number of micronucleated PCEs scored per 1000 cells, not 2000
- Qualifier:
- according to guideline
- Guideline:
- other: EPA Health Effect T G, EPA Report 560/6-83-001
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- Swiss Webster
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Portage, MI
- Age at study initiation: 5 weeks
- Weight at study initiation: male - 22.5 g - 28.0 g. female - 19.8 g - 21.7 g
- Assigned to test groups randomly: randomised separately by sex
- Fasting period before study: no
- Housing: 5 mice/sex/cage in shoe-box type plastic cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): controlled but not specified
- Humidity (%): controlled but not specified
- Air changes (per hr): not known
- Photoperiod (hrs dark / hrs light): 12 hr light/dark cycle - Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: incompatible with water thus corn oil was used
- Concentration of test material in vehicle: 200 mg/kg - Duration of treatment / exposure:
- single i p dose
- Frequency of treatment:
- One treatment only
- Post exposure period:
- 30, 48 and 72 hours
- Dose / conc.:
- 87.5 mg/kg bw/day
- Dose / conc.:
- 175 mg/kg bw/day
- Dose / conc.:
- 280 mg/kg bw/day
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Positive control(s):
- Triethylenemelamine
- Justification for choice of positive control(s): known to demonstrate the sensitivity and responsiveness of the animals in the definitive test.
- Route of administration: i p
- Doses / concentrations: 0.3 mg/kg bw - Tissues and cell types examined:
- Blood was collected by nicking the tail of each animal with a scalpel and slides prepared for each animal per sampling time. Polychromatic erythrocytes (PCE's) were examined.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Determination of the PCE/NCE ratio for the groups of animals with partial mortality was used to evaluate the possibility of bone marrow cytotoxicity from the test chemical. Three dose levels of approximately 80%, 50% and 25% of the LD50 value were evaluated for effects upon the incidence of micronuclei.
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): i.p. injection followed by sampling times of 30, 48 and 72 hours
DETAILS OF SLIDE PREPARATION: Slides were stained with Gurr's R-66 Giemsa diluted in phosphate buffer. Slides were coded by animal number only and read blindly.
METHOD OF ANALYSIS: A minimum of 1000 PCE's were examined microscopically for each animal per sample time. The PCE/NCE ratio for approximately 1000 total cells was calculated and recorded. The number of micronucleated PCE/1000 NCE was recorded. - Evaluation criteria:
- A test result is considered to be negative if no statistically significant or dose related increases are apparent between the vehicle control and groups of animals treated with Organofunctional Silane A-1120.
- Statistics:
- Fisher's Exact Test (Sokal and Rohlf, 1981)
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- LD50 354 mg/kg bw and above. PCE/NCE ratio was reduced at highest concentration, 48 h exposure and at all doses, 72 h exposure.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 125 mg/kg bw - 2000 mg/kg b
- Solubility: Incompatible with water thus corn oil was used
- Clinical signs of toxicity in test animals: All mice dosed at 1000 mg/kg bw and 2000 mg/kg bw died. 500 mg/kg bw was lethal to 4 out of 5 females and all the male mice. One female tested at 250 mg/kg bw died.
- Evidence of cytotoxicity in tissue analyzed: a decrease in the PCE/NCE ratio to 80% of the control value was observed at the 48 hour treatment interval. At 72 hours the PCE/NCE ratios had increased.
- Harvest times: 48 hours
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): negative.
- Ratio of PCE/NCE (for Micronucleus assay): PCE/NCE ratio was slightly decreased at 72 hour treatment interval.
- Appropriateness of dose levels and route: Both dose levels and route were appropriate.
- Statistical evaluation: Analysis of variance indicated no sex-related differences in the incidence of micronuclei. No statistically significant (p ≤ 0.01) or treatment related increases in the numbers of micronuclei were observed at any dose or treatment interval. - Conclusions:
- N-(3-(trimethoxysilyl)propyl)ethylenediamine has been tested in a reliable study according to EPA Health Effect T G, Report 560/6-83-001, which is similar to OECD 474, and under GLP conditions. No treatment related increases in numbers of micronuclei in PCE's of Swiss-Webster mice were observed. Relatively high dose levels of the test compound were tested up to 80% of the LD50 with no indication of significant induction of micronuclei. The PCE/NCE ratio was reduced at the highest concentration, 48 h exposure and at all doses, 72 h exposure, indicating exposure of the target tissue to the test substance. The test compound is considered to be negative for the induction of micronuclei under the conditions of this test.
Reference
Table 3: Summary of micronucleus results
|
30 hours |
48 hours |
72 hours |
|||||||||
Treatment groups mg/kg bw |
Number of PCE’s with micronuclei per 1000 PCE’s |
Mean PCE’s/1000 NCE (SD) |
Number of PCE’s with micronuclei per 1000 PCE’s |
Mean PCE’s/1000 NCE (SD) |
Number of PCE’s with micronuclei per 1000 PCE’s |
Mean PCE’s/1000 NCE (SD) |
||||||
Male |
Female |
Group mean |
SD |
Male |
Female |
Group mean |
SD |
Male |
Female |
Group mean |
SD |
|
Vehicle control |
4.0 (2.00) |
1.6 (0.89) |
33.7 |
5.52 |
2.4 (2.70) |
3.6 (1.14) |
36.4 |
4.24 |
3.8 (2.05) |
3.8 (2.68) |
42.9 |
3.25 |
87.5 |
5.0 (2.55) |
3.6 (1.52) |
31.8 |
6.79 |
3.0 (1.73) |
2.2 (0.84) |
36.0 |
0.28 |
6.4 (2.19) |
2.8 (1.64) |
33.9 |
2.12 |
175 |
2.6 (1.52) |
4.0 (1.22) |
34.9 |
8.06 |
3.2 (1.10) |
3.8 (1.64) |
37.2 |
7.92 |
2.3 (0.96) |
5.2 (3.96) |
35.5 |
6.68 |
280 |
3.4 (2.19) |
3.6 (2.19) |
35.4 |
4.81 |
3.4 (3.29) |
3.0 (1.22) |
30.4 |
3.39 |
3.8 (1.92) |
1.2 (0.84) |
27.9 |
1.27 |
Positive control |
36.2 (16.84) |
28.6 (10.31) |
27.4 |
9.05 |
Not evaluated |
Not evaluated |
Not evaluated |
Not evaluated |
Table 4 Summary of micronucleus frequency and statistical differences from controls (Fisher's exact test, one-tailed)
Treatment/dose mg/kg bw |
No. PCE observed |
PCE with micronuclei |
Statistical significance |
|
30 hour sample |
||
Vehicle control |
10 000 |
28 |
NS |
87.5 |
10 000 |
43 |
0.05>p>0.01* |
175 |
10 000 |
33 |
NS |
280 |
10 000 |
35 |
NS |
Positive control |
10 000 |
324 |
p<0.001 |
|
48 hour sample |
||
Vehicle control |
10 000 |
30 |
NS |
87.5 |
10 000 |
26 |
NS |
175 |
10 000 |
35 |
NS |
280 |
10 000 |
32 |
NS |
|
72 hour sample |
||
Vehicle control |
10 000 |
38 |
NS |
87.5 |
10 000 |
46 |
NS |
175 |
10 000 |
35 |
NS |
280 |
10 000 |
25 |
NS |
Results from sexes are combined as no sex-related differences were shown.
* not considered of biological significance
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Information is available for all the required endpoints for N-(3 -(trimethoxysilyl)propyl)ethylenediamine.
N-(3-(trimethoxysilyl)propyl)ethylenediamine has been tested for mutagenicity to bacteria, in a study that was conducted according to the OECD TG 471 and in compliance with GLP (DCC (1999)). No evidence of test substance related increase in the number of revertants was observed with or without activation in the initial or the repeat experiments using the plate incorporation method in Salmonella typhimurium strains TA 98, TA 100, TA 153, TA 1537, E coli WP2 trp uvrA pKM101 (CM891) and E coli WP2 trp pKM101 (CM881). The solvent used was water, and hydrolysis was likely to have occurred under test conditions, so it is assumed that exposure was to the hydrolysis product as well as the parent substance. It is not considered to invalidate the study, as it is considered that hydrolysis may occur in vivo. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test. The result of this study is supported by four older studies, where non-aqueous solvents were used: the results of all the studies on bacterial mutagenicity are in agreement. The most reliable study was selected as key.
N-(3-trimethoxysilyl)propyl)ethylenediamine has been tested in a reliable study according to an appropriate US EPA test guideline that is equivalent to OECD 476 and under GLP (Slesinski and Guzzie (1988)). An increase in mutant frequency was observed in one of two duplicate cultures with metabolic activation at one concentration in the initial experiment. No other increase in mutant frequency was observed at any concentration with and without activation (5 hours treatment). The experiment was repeated (with metabolic activation): no increase in mutant frequency was observed. The appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of mutations in CHO cells under the conditions of the test.
No in vitro cytogenicity study is available; testing is not required as a reliable in vivo micronucleus assay is available.
A reliable in vitro sister chromatid assay is available, conducted according to a US EPA protocol that is similar to OECD TG 479 and under GLP (Slesinski and Guzzie (1988)). N-(3-(trimethoxysilyl)propyl)ethylenediamine did not induce statistically and biologically significant increases in the sister chromatid exchange frequency of CHO cells. A slight statistically significant increase in the sister chromatid exchange frequency of CHO cells was not considered of biological significance as the level of increase was very low, and was not dose related. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of sister chromatid exchange in vitro under the conditions of the test. This study is not considered key as it does not correspond to a standard REACH endpoint.
N-(3-(trimethoxysilyl)propyl)ethylenediamine has been tested in a reliable in vivo micronucleus study according to EPA Health Effect T G, Report 560/6-83-001, which is similar to OECD 474, and under GLP conditions (BRRC (1988)). No treatment related increases in numbers of micronuclei in PCE's of Swiss-Webster mice were observed after intraperitoneal administration. Relatively high dose levels of the test compound were tested up to 80% of the LD50 with no indication of significant induction of micronuclei. The PCE/NCE ratio was reduced at the highest concentration, 48 h exposure and at all doses, 72 h exposure, indicating exposure of the target tissue to the test substance. The test compound is considered to be negative for the induction of micronuclei under the conditions of this test.
No evidence of mutagenicity or clastogenicity was observed in any of the available in vitro and in vivo studies.
Justification for classification or non-classification
Based on the available in vitro and in vivo genotoxicity data N-(3-(trimethoxysilyl)propyl)ethylenediamine is not classified for mutagenicity according to Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.